Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05735834
Title Comparison Between Rituximab Plus Zanubrutinib Versus Rituximab Monotherapy in Untreated SMZL Patients (RITZ)
Acronym RITZ
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors International Extranodal Lymphoma Study Group (IELSG)
Indications
Therapies
Age Groups: senior | adult
Covered Countries SWE | NOR | ITA | GBR | FRA | ESP | DNK | CHE | AUT


No variant requirements are available.